Literature DB >> 401947

Cmu4 domain of IgM has cytophilic activity for human lymphocytes.

J D Conradie, M O Bubb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401947     DOI: 10.1038/265160a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Evidence for the presence of a receptor for IgM on the pathological cells of Sézary's syndrome.

Authors:  C P Worman; G F Burns; C R Barker
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

2.  Study of some properties of the receptor for IgM on human lymphocytes.

Authors:  S Romagnani; E Maggi; M Lorenzini; G M Giudizi; R Biagiotti; M Ricci
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

3.  Studies on the structural and biological functions of the Cmu4 domains of IgM.

Authors:  M O Bubb; J D Conradie
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

Review 4.  Characteristics and function of Fc receptors on human lymphocytes.

Authors:  P M Lydyard; M W Fanger
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

5.  Binding of different ligands to IgM-Fc receptors of rat leucocytes.

Authors:  F Uher; I Dobronyi; J Gergely
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

6.  The in vitro culture characteristics and requirements for expression of receptors for IgM on human peripheral blood lymphocytes.

Authors:  M G Golightly; S H Golub
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

7.  IgM receptors on human lymphocytes: detection by direct binding.

Authors:  J A Hardin; K K Nakaoka; J M Carboni
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

8.  Receptors for IgM on human lymphocytes. III. Specificity of receptors.

Authors:  M W Fanger; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.